C3 Glomerulopathy: Pathogenesis and Treatment

This publication has 39 references indexed in Scilit:

• Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation
  Journal of the American Society of Nephrology, 2014
• Anti-Complement Therapy for Glomerular Diseases
  Advances in Chronic Kidney Disease, 2014
• Toward a working definition of C3 glomerulopathy by immunofluorescence
  Kidney International, 2014
• C3 glomerulopathy: consensus report
  Kidney International, 2013
• C3 Glomerulonephritis Associated With Monoclonal Gammopathy: A Case Series
  American Journal of Kidney Diseases, 2013
• Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
  Kidney International, 2012
• C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up
  Kidney International, 2012
• Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
  Clinical Journal of the American Society of Nephrology, 2012
• Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis
  Eye, 2001
• Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.
  Journal of Experimental Medicine, 1992